Skip to main content

MoneyWorks4Me

GlaxoSmithKline Pharmaceuticals submits analyst meet intimation

13 May 2025 Evaluate
Pursuant to Regulation 30 read with Part A of Schedule Ill of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, GlaxoSmithKline Pharmaceuticals has enclosed the presentation to be made in Investors / Analysts Call and the same is also being uploaded on the website of the Company.

The above information is a part of company’s filings submitted to BSE.



Peers
Company Name CMP
Sun Pharma. Inds. 1787.30
Dr. Reddys Labs. 1350.00
Cipla 1366.70
Lupin 1988.30
Zydus Lifesciences 1227.85
View more..